Intercept Pharmaceuticals, Inc.
Compositions of obeticholic acid and methods of use

Last updated:

Abstract:

The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and methods of treating various diseases and conditions.

Status:
Grant
Type:

Utility

Filling date:

11 Feb 2020

Issue date:

1 Sep 2020